CXCL9 & CXCL11 Levels in Patients With Autoimmune NCT01644318

Updated 05/10/2024

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number	NCT01644318
Other study ID #	3848
Secondary ID
Status	Active, not recruiting
Phase	N/A
First received	July 17, 2012
Last updated	July 18, 2012

Study information
Verified date	July 2012
Source	Ankara Education and Research Hospital
Contact	n/a
Is FDA regulated	No
Health authority	Turkey: Ethics Committee
Study type	Observational

Clinical Trial Summary

The purpose of this study is to measure serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions

Recruitment information / eligibility
Status	Active, not recruiting
Enrollment	0
Est. completion date
Est. primary completion date
Accepts healthy volunteers
Gender	Female
Age group	20 Years to 40 Years
Eligibility	Inclusion Criteria: - non-pregnant women with euthyroid autoimmune thyroiditis and a history of first trimester recurrent spontaneous abortions Exclusion Criteria: - 1) presence of acute or chronic systemic diseases; 2) other autoimmune diseases; 3) pregnancy and lactation over the previous 6 months; 4) evidence of infectious diseases in the last 3 months; 5) treatment with drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs, amiodarone, and lithium; 6) clinical history of hyperthyroidism and/or the presence of anti-TSH receptor antibodies.

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country	Name	City	State
Turkey	Ankara Education and Research Hospital	Ankara

Sponsors *(1)*
Lead Sponsor	Collaborator
Ankara Education and Research Hospital

Country where clinical trial is conducted

Turkey,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05725512` - Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages	Phase 2
	Completed	`NCT00959621` - Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion	Phase 3
	Completed	`NCT00772122` - Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage	Phase 4
	Completed	`NCT04017754` - Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)
	Recruiting	`NCT04701034` - Intravenous Immunoglobulin and Prednisolone for RPL After ART.	Phase 2
	Recruiting	`NCT05169541` - Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction